Amalie Holmgaard Mersh, EurActiv

Amalie Holmgaard Mersh

EurActiv

Germany

Contact Amalie

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • EurActiv

Past articles by Amalie:

Deadline for COVID-19 diagnostics, therapeutics waiver to be extended

The World Trade Organisation (WTO) Council on Trade-related aspects of Intellectual Property Rights (TRIPS) recommended postponing the deadline on whether to extend the TRIPS waiver to include COVID-19 diagnostics and therapeutics, as well as vaccines. → Read More

Many actions can be taken on health before changing treaties, say MEPs

There are many more accessible actions that can be taken on health before getting onto the bigger question of changing the EU treaties, EU lawmakers said in a health committee meeting on Monday (5 December). → Read More

EU Global Health Strategy lacks ambition on climate change, says expert

Giving climate change a more clear role in the EU Global Health Strategy is necessary to plan for future health threats, Alan Dangour, director of climate and health at the Wellcome Trust said. → Read More

EU ministers to scrap cross-border telemedicine from health data space

The Czech EU Council presidency is expected to reach a common position just on the first two chapters of the European Health Data Space (EHDS) file, in which ministers will propose scrapping the European Commission's provisions on cross-border telemedicine. → Read More

Available therapeutics may be ineffective against new COVID sub-variants

Available monoclonal antibody medicines may not be effective against the new COVID-19 omicron sub-variants, the European Medicines Agency (EMA) has warned. → Read More

Health commissioner quizzed on curbing medical device shortage

MEPs questioned EU health commissioner Stella Kyriakides about the risk of shortages of medical devices as the transition into a new framework for these products is not progressing smoothly. → Read More

EU drugs agency: Rising use of laughing gas cause for concern

Recreational use of nitrous oxide - also known as laughing gas - is on the rise in EU countries despite risks of harm associated with the drug, a new report from the EU drugs agency shows. → Read More

Commission: New wastewater rules will not jeopardise access to medicines

The EU Commission rejected a warning from pharmaceutical companies that extended producer responsibility (EPR) under the proposed revision of the wastewater directive could jeopardise access to medicines. → Read More

35,000 annual deaths in Europe due to superbugs, says EU agency

As deaths due to antimicrobial resistance (AMR) rise, public health actions aimed at tackling AMR are insufficient, according to a report by the European Centre for Disease Prevention and Control (ECDC) published Thursday (17 November). → Read More

Adult immunisation key in shift towards preventative health

European populations are growing older, increasing the burden on already struggling health systems, but one way of reducing the burden is through adult immunisation programmes to combat vaccine-preventable diseases. → Read More

Proposal to revise EU orphan medicines legislation expected next month, says Commission

Without providing a specific date, a Commission representative told MEPs in the European Parliament’s health committee (ENVI) that they expect to adopt the proposal for a revision of the orphan medicinal products legislation next month. → Read More

More action must be taken on cardiovascular diseases in Europe, says expert

With cardiovascular diseases being the leading cause of death in Europe, we must significantly step up efforts to address them early on in life, paediatrician and professor at the University of Ljubljana, Urh Groselj, has urged. → Read More

Discussions for waiver on COVID-19 diagnostics and therapeutics at standstill

No progress has been made on the decision to extend the waiver of part of the World Trade Organisation (WTO) agreement on Trade-related aspects of Intellectual Property Rights (TRIPS) to COVID-19 diagnostics and therapeutics, despite the looming deadline. → Read More

Fast-developing COVID-19 variants emerge as new wave moves over Europe

The virus is faster than we can ever be in adapting vaccines, Marco Cavaleri, head of health threats and vaccines strategy at the European Medicines Agency (EMA), told MEPs on Wednesday (October 26). → Read More

Climate action 'biggest public health opportunity of the century', says report

A new report from the scientific journal The Lancet has warned of the need to act to avoid serious health effects of slow climate action and adaptation, calling action the "biggest public health opportunity of the century". → Read More

European Care Strategy must highlight informal carers, gender aspects

Informal care workers, gender gaps, and recognition of the NGOs' importance need to be better addressed in the European Commission's European Care Strategy, according to EU lawmakers and health stakeholders. → Read More

New mental health strategy must involve everyone, EU Commissioner

A strategy in mental health, first announced by European Commission President Ursula von der Leyen, is on next year's agenda, Commission Vice-President Maroš Šefčovič told a Parliamentary plenary debate on Tuesday (18 October). → Read More

DG SANTE chief: EU Global Health Strategy to deal with health over development

The forthcoming EU global strategy for health will rely less on development policy, unlike in the past, and focus more on pure health issues, Commission's health policy 'number-two' told EURACTIV in an interview. → Read More

Health economist: Better data on inequalities needed for EU Cancer Plan to work

The ambitious goals of Europe's Beating Cancer will be out of reach without prioritising the gathering of necessary data to gain a more accurate picture of inequalities in cancer care, according to a health economist. → Read More

WHO: Action against out-of-pocket payments must target most vulnerable

Out-of-pocket medical payments are an increasing challenge in the midst of a cost of living crisis. To avoid more catastrophic health spending, politicians must target the most vulnerable, says the World Health Organisation (WHO). → Read More